Stock Price
2.25
Daily Change
0.03 1.35%
Monthly
-1.75%
Yearly
143.24%
Q3 Forecast
2.11

Mesoblast reported $8.97M in Cost of Sales for its fiscal semester ending in June of 2024.




Cost Of Sales Change Date
Avita Medical AUD 2.28M 170K Dec/2024
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Cochlear AUD 290.1M 20.2M Dec/2024
CSL USD 3.93B 527M Dec/2024
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 18.72K 9.73K Dec/2024
PYC Therapeutics AUD 3.1M 2.8M Dec/2020
Ramsay Health Care AUD 2.23B 6.3M Dec/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Starpharma Holdings AUD 348K 2.26M Dec/2024
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024